Physician profile
Peter A Macdonald
NPI 1699797092
$298.99
in general payments reported to CMS, 2019-2025
10 companies · $13.76 in 2025
The $13.76 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $149 · 2023: $15.16 · 2025: $13.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.16 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.16 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $148.84 | 2021 | |
| Pfizer INC. | $28.10 | 2019 | |
| Novo Nordisk INC | $23.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.88 | 2019 | |
| Amgen INC. | $15.16 | 2023 | Otezla, Repatha |
| Teva Pharmaceuticals USA, INC. | $14.26 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2025 | Eohilia |
| Supernus Pharmaceuticals, INC. | $13.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.59 | 2019 | |
| Glaxosmithkline, LLC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.